Koen W van Besien

26PUBLICATIONS
112CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 07, 2026
A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation.

|Jul 28, 2026
Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

|Aug 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.

Seda S Tolu, Caitlin Gribbin, Zhengming Chen

|Apr 03, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Niloufer Khan, Parastoo B Dahi, Farhad Khimani

|Sep 19, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|Sep 09, 2024
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.

Chenyu Lin, Anand A Patel, Dezheng Huo

Pageof 5

Frequent Collaborators

5 joint publications

Tsiporah Shore

3 joint publications

Michael Daunov

3 joint publications

Alexandra Gomez-Arteaga

3 joint publications

Benjamin Tomlinson